2024 | Artificial Intelligence Enhanced Drug Discovery and Repurposing - From Benchside to Bedside

The process of bringing a new drug to market has a high failure rate, a timeline of 10-15 years, and a cost of more than $1 billion. Artificial intelligence coupled with the use of patient-derived cells and tissues can be leveraged to perform personalized drug screening and enhance the success of drug discovery, especially for rare diseases.

Jonny Sexton, PhD, earned his undergraduate degree in chemistry at UC Santa Barbara and his PhD in chemistry at UC Santa Barbara.   He then did a postdoctoral fellowship at Stanford University with Nobel Laureate Roger Kornberg.   In 2007, he took a faculty position at the University of North Carolina.  Following that he was the director of Drug Discovery at the BRITE Institute.  In 2018, he moved to the University of Michigan where he started a laboratory focusing on artificial intelligence enhanced drug discovery, particularly for chronic liver diseases.  Currently he is the faculty director of the UM Center for Drug Repurposing.

Program will also be available live through Zoom.